Butantan Institute requests definitive registration of CoronaVac

A year and a half after the approval of the emergency use of the CoronaVac vaccine against COVID-19, Brazil’s national drug regulator Anvisa received the application for its definitive registration. The request was sent by the Butantan Institute of São Paulo. The immunizer had been approved in Brazil on January 17, 2021, for adults and […]

Fonte